| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
phenotype | 0.120 | None | 1.000 | 2 | 0 | 2004 | 2006 | ||||||||
|
keratin 17 | 0.531 | 0.654 | 1.1E-11 |
|
phenotype | 0.110 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
periostin | 0.428 | 0.885 | 1.1E-09 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2008 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2019 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2003 | ||||||||
|
phospholipase A2 group IVA | 0.496 | 0.846 | 6.0E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
polycystin 2, transient receptor potential cation channel | 0.552 | 0.731 | 1.7E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
BRCA2 and CDKN1A interacting protein | 0.705 | 0.385 | 7.9E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
patched 1 | 0.398 | 0.885 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
plexin A2 | 0.447 | 0.808 | 1.1E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ADAM metallopeptidase domain 10 | 0.489 | 0.846 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | ||||||||
|
syndecan 1 | 0.445 | 0.769 | 8.4E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
Zic family member 2 | 0.556 | 0.769 | 0.97 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
polycystin 1, transient receptor potential channel interacting | 0.493 | 0.769 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
mucin 2, oligomeric mucus/gel-forming | 0.486 | 0.808 | 9.4E-10 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
MT-CO2 pseudogene 12 | 0.368 | 0.962 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
caspase 14 | 0.663 | 0.462 | 2.9E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
fyn related Src family tyrosine kinase | 0.674 | 0.500 | 1.8E-12 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
nuclear receptor subfamily 5 group A member 1 | 0.479 | 0.731 | 0.99 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
immunoglobulin heavy variable 1-12 (pseudogene) | 0.569 | 0.654 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 |